As of 2025-09-17, the Relative Valuation of Travere Therapeutics Inc (TVTX) is (31.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.77 USD, the upside of Travere Therapeutics Inc based on Relative Valuation is -238.3%.
The range of the Relative Valuation is (30.27) - (35.65) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.5x - 18.8x | 13.7x |
| Forward P/E multiples | 16.0x - 25.6x | 19.5x |
| Fair Price | (30.27) - (35.65) | (31.48) |
| Upside | -232.9% - -256.6% | -238.3% |
| Date | P/E |
| 2025-09-16 | -12.01 |
| 2025-09-15 | -12.13 |
| 2025-09-12 | -12.38 |
| 2025-09-11 | -13.18 |
| 2025-09-10 | -14.40 |
| 2025-09-09 | -11.41 |
| 2025-09-08 | -11.18 |
| 2025-09-05 | -11.41 |
| 2025-09-04 | -11.15 |
| 2025-09-03 | -10.34 |
| 2025-09-02 | -9.57 |
| 2025-08-29 | -9.23 |
| 2025-08-28 | -9.33 |
| 2025-08-27 | -9.20 |
| 2025-08-26 | -9.20 |
| 2025-08-25 | -9.09 |
| 2025-08-22 | -9.45 |
| 2025-08-21 | -9.38 |
| 2025-08-20 | -9.48 |
| 2025-08-19 | -9.30 |
| 2025-08-18 | -9.90 |
| 2025-08-15 | -9.92 |
| 2025-08-14 | -9.61 |
| 2025-08-13 | -9.52 |
| 2025-08-12 | -9.18 |
| 2025-08-11 | -9.11 |
| 2025-08-08 | -8.93 |
| 2025-08-07 | -8.92 |
| 2025-08-06 | -9.09 |
| 2025-08-05 | -8.80 |
| 2025-08-04 | -8.42 |
| 2025-08-01 | -8.24 |
| 2025-07-31 | -8.15 |
| 2025-07-30 | -8.16 |
| 2025-07-29 | -8.19 |
| 2025-07-28 | -8.12 |
| 2025-07-25 | -8.08 |
| 2025-07-24 | -8.41 |
| 2025-07-23 | -8.51 |
| 2025-07-22 | -8.26 |
| 2025-07-21 | -8.34 |
| 2025-07-18 | -8.49 |
| 2025-07-17 | -8.71 |
| 2025-07-16 | -8.78 |
| 2025-07-15 | -8.64 |
| 2025-07-14 | -8.92 |
| 2025-07-11 | -8.68 |
| 2025-07-10 | -8.73 |
| 2025-07-09 | -8.61 |
| 2025-07-08 | -8.07 |